| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 816.36B | 1.09T | 1.16T | 1.26T | 1.15T | 1.07T |
| Gross Profit | 78.24B | 104.72B | 116.34B | 129.98B | 115.57B | 109.57B |
| EBITDA | 26.17B | 66.60B | 48.64B | 53.56B | 73.34B | 67.71B |
| Net Income | 15.56B | 22.89B | 27.89B | 33.48B | 31.27B | 27.62B |
Balance Sheet | ||||||
| Total Assets | 2.42T | 2.47T | 2.26T | 1.83T | 1.61T | 1.36T |
| Cash, Cash Equivalents and Short-Term Investments | 194.28B | 266.30B | 262.09B | 243.39B | 248.76B | 186.07B |
| Total Debt | 566.34B | 520.19B | 467.10B | 380.07B | 390.36B | 295.58B |
| Total Liabilities | 1.88T | 1.93T | 1.75T | 1.37T | 1.19T | 1.00T |
| Stockholders Equity | 374.29B | 371.06B | 354.71B | 332.53B | 301.23B | 275.27B |
Cash Flow | ||||||
| Free Cash Flow | -40.77B | -31.51B | -29.95B | -20.08B | -18.76B | -42.90B |
| Operating Cash Flow | 13.00B | 28.77B | 28.05B | 38.36B | 43.55B | 13.07B |
| Investing Cash Flow | -40.94B | -45.26B | -82.29B | -74.64B | -84.39B | -77.46B |
| Financing Cash Flow | 31.15B | 28.68B | 57.39B | 27.13B | 96.36B | 67.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$48.23B | 3.19 | 11.89% | 6.69% | -5.48% | -4.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$25.40B | 18.56 | 5.62% | 5.31% | 9.27% | -27.28% | |
57 Neutral | HK$87.59B | 8.64 | 4.96% | 3.90% | 5.40% | -33.06% | |
57 Neutral | HK$62.97B | 4.48 | 0.95% | 3.21% | -17.50% | -75.50% | |
53 Neutral | HK$130.59B | 5.02 | 6.18% | 7.43% | -5.68% | -21.80% | |
52 Neutral | HK$17.61B | 22.20 | 6.83% | ― | -3.56% | 49.92% |